Amanta Healthcare Limited disclosed that Ms. Dypal Jain, immediate relative to Director Shri Nitin Jain, purchased 15,675 equity shares through open market transactions between March 19-24, 2026, valued at ₹15.01 lakh. The transactions were executed on NSE and BSE exchanges, increasing her total shareholding to 15,676 shares (0.04% of equity capital). The company submitted the required SEBI insider trading disclosure on March 26, 2026.

Amanta Healthcare Reports Insider Purchase of 15,675 Equity Shares by Director's Relative

Amanta Healthcare Limited has submitted a disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding an open market purchase of equity shares by an insider.

Transaction Details

Ms. Dypal Jain, who is an immediate relative to Director Shri Nitin Jain, acquired 15,675 equity shares of the company through open market purchases conducted between March 19, 2026, and March 24, 2026.

Parameter: Details Purchaser: Ms. Dypal Jain Relationship: Immediate relative to Director Shri Nitin Jain Number of Shares: 15,675 Transaction Value: ₹15.01 lakh Transaction Period: March 19-24, 2026 Exchanges: NSE and BSE

Shareholding Position

Prior to this transaction, Ms. Dypal Jain held 1 equity share representing a negligible percentage of the company's total shareholding. Following the acquisition of 15,675 additional shares, her total shareholding has increased to 15,676 equity shares, representing 0.04% of the company's equity capital.

Shareholding Details: Before Transaction After Transaction Number of Shares: 1 15,676 Percentage Holding: Negligible % 0.04% Security Type: Equity Shares Equity Shares

Regulatory Compliance

The company received the disclosure in Form 'C' pursuant to Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, dated March 25, 2026. The disclosure was submitted to both BSE Limited and National Stock Exchange of India Limited on March 26, 2026, by Company Secretary and Compliance Officer Nikhita Dinodia.

The transaction represents a market purchase executed through regular trading mechanisms on both major Indian stock exchanges, demonstrating compliance with insider trading disclosure requirements under SEBI regulations.

Amanta Healthcare Limited has disclosed that its promoter Bhavesh Girishbhai Patel has increased his stake in the company through open market purchases. The transaction was disclosed under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Transaction Details

The promoter acquired 48,151 equity shares of the company through market purchases executed on February 26, 2026 and February 27, 2026. The shares were purchased through the National Stock Exchange (NSE) platform.

Parameter: Details Number of Shares Acquired: 48,151 Transaction Value: ₹50,20,647.16 Purchase Dates: February 26-27, 2026 Exchange: NSE Mode: Market Purchase

Shareholding Pattern Changes

Following the acquisition, Bhavesh Patel's shareholding in Amanta Healthcare has increased marginally. The transaction represents a strategic investment by the promoter in the company's equity.

Shareholding Details: Before Transaction After Transaction Number of Shares: 62,49,593 62,97,744 Percentage Holding: 16.10% 16.22% Share Type: Equity Shares Equity Shares

Regulatory Compliance

The company submitted the disclosure in Form 'C' to both BSE Limited and National Stock Exchange of India Limited on February 27, 2026. The disclosure was signed by Company Secretary and Compliance Officer Nikhita Dinodia, ensuring compliance with insider trading regulations.

The promoter confirmed that no derivative trading was undertaken in connection with this transaction. The disclosure includes complete details of the promoter's contact information and PAN details as required under SEBI regulations.

Company Information

Amanta Healthcare Limited is listed on both BSE (Scrip Code: 544502) and NSE (Trading Symbol: AMANTA). The company's registered and corporate office is located at 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.